FDA slams Novo Nordisk for misleading Ozempic ad in second warning
The U.S. Food and Drug Administration (FDA) has issued a formal warning to Novo Nordisk over a misleading advertisement for Ozempic. The agency claims the commercial made false statements about the diabetes drug's benefits and downplayed safety risks. This marks the second reprimand for the company in less than a month.
The FDA's warning targets the Ozempic commercial titled 'There's Only One Ozempic'. Regulators argue the ad falsely suggests the drug has more FDA-approved uses than competitors, implying universal benefits without proper evidence. They also criticise the placement of safety warnings, which appear only after the closing jingle and manufacturer's logo, making them easy to overlook.
This latest action follows a similar warning last month regarding Novo Nordisk stock and its weight-loss drug Wegovy. The FDA has given the company 15 business days to submit a formal response to the allegations.
The crackdown is part of a wider FDA campaign against deceptive drug advertising. Over the past year, from March 2025 to March 2026, the agency has sent warning letters to 47 companies, including major firms like PharmaCorp and Medix Labs. The push for stricter oversight comes after an executive order by then-U.S. President Donald Trump calling for tougher regulation of pharmaceutical marketing.
Novo Nordisk must now address the FDA's concerns within the given deadline. The outcome could impact how the company advertises Ozempic and other drugs in the future. The case also highlights the agency's ongoing efforts to enforce transparency in pharmaceutical promotions.
Read also:
- American teenagers taking up farming roles previously filled by immigrants, a concept revisited from 1965's labor market shift.
- Weekly affairs in the German Federal Parliament (Bundestag)
- Landslide claims seven lives, injures six individuals while they work to restore a water channel in the northern region of Pakistan
- Escalating conflict in Sudan has prompted the United Nations to announce a critical gender crisis, highlighting the disproportionate impact of the ongoing violence on women and girls.
